Ophthalmia neonatorum

Revision as of 19:00, 12 September 2016 by Sara Mehrsefat (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Ophthalmia neonatorum

WikiDoc Resources for Ophthalmia neonatorum

Articles

Most recent articles on Ophthalmia neonatorum

Most cited articles on Ophthalmia neonatorum

Review articles on Ophthalmia neonatorum

Articles on Ophthalmia neonatorum in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ophthalmia neonatorum

Images of Ophthalmia neonatorum

Photos of Ophthalmia neonatorum

Podcasts & MP3s on Ophthalmia neonatorum

Videos on Ophthalmia neonatorum

Evidence Based Medicine

Cochrane Collaboration on Ophthalmia neonatorum

Bandolier on Ophthalmia neonatorum

TRIP on Ophthalmia neonatorum

Clinical Trials

Ongoing Trials on Ophthalmia neonatorum at Clinical Trials.gov

Trial results on Ophthalmia neonatorum

Clinical Trials on Ophthalmia neonatorum at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ophthalmia neonatorum

NICE Guidance on Ophthalmia neonatorum

NHS PRODIGY Guidance

FDA on Ophthalmia neonatorum

CDC on Ophthalmia neonatorum

Books

Books on Ophthalmia neonatorum

News

Ophthalmia neonatorum in the news

Be alerted to news on Ophthalmia neonatorum

News trends on Ophthalmia neonatorum

Commentary

Blogs on Ophthalmia neonatorum

Definitions

Definitions of Ophthalmia neonatorum

Patient Resources / Community

Patient resources on Ophthalmia neonatorum

Discussion groups on Ophthalmia neonatorum

Patient Handouts on Ophthalmia neonatorum

Directions to Hospitals Treating Ophthalmia neonatorum

Risk calculators and risk factors for Ophthalmia neonatorum

Healthcare Provider Resources

Symptoms of Ophthalmia neonatorum

Causes & Risk Factors for Ophthalmia neonatorum

Diagnostic studies for Ophthalmia neonatorum

Treatment of Ophthalmia neonatorum

Continuing Medical Education (CME)

CME Programs on Ophthalmia neonatorum

International

Ophthalmia neonatorum en Espanol

Ophthalmia neonatorum en Francais

Business

Ophthalmia neonatorum in the Marketplace

Patents on Ophthalmia neonatorum

Experimental / Informatics

List of terms related to Ophthalmia neonatorum

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [4]

Synonyms and keywords: Neonatal Conjunctivitis

Overview

Ophthalmia neonatorum is a form of conjunctivitis contracted by newborns during delivery. The baby's eyes are contaminated during passage through the birth canal from a mother infected with either Neisseria gonorrhoeae or Chlamydia trachomatis. Typical treatment is silver nitrate drops. If left untreated it can cause blindness.

Ophthalmia neonatorum, also known as neonatal conjunctivitis, can also be caused by other bacteria, viruses, and chemical irritants (such as silver nitrate). Thus, silver nitrate is not used very often, anymore, because it can cause chemical conjunctivitis, which usually clears up within 2 to 4 days. In most countries neomycin and chloramphenicol eye drops are being used instead.

Ophthalmia neonatorum due to gonococci (Neisseria gonorrhoeae) typically manifests in the first 5 days of life and is associated with marked bilateral purulent discharge. In contrast, conjunctivitis secondary to infection with chlamydia (Chlamydia trachomatis) produces conjunctivitis after day 3 of life, but may occur up to 2 weeks after delivery. Babies infected with chlamydia may develop pneumonitis (chest infection) at a later stage (range 2 weeks - 19 weeks after delivery). Infants with chlamydia pneumonitis should be treated with oral erythromycin for 14 days.[1]

Historical Perspective

  • In 1750, neonatal conjunctivitis (ophthalmia neonatorum) was first described by S.T. Quellmaz.[2]
  • In 1881, Crédé introduced 2% silver nitrate for the first time as a prophylaxis treatment method for conjunctivitis in the newborns in Leipzig.[3]

Classification

According to the etiology ophthalmia neonatorum may be classified into::[2]

Pathophysiology

Pathogenesis

Neonatal conjunctivitis is occurring in a newborn during the first month of life, and often known as ophthalmia neonatorum. Neonatal conjunctivitis is mainly caused by sexually transmitted diseases agents such as Chlamydia trachomatis, Neisseria gonorrhoeae, and herpes simplex virus (HSV). Chlamydia trachomatis is the most common cause of ophthalmia neonatorum in the developed countries because of higher prevalence of chlamydia as a sexually transmitted disease.

The recognized routes of transmission of the organisms to the newborns include:[4]

  • Infected birth canal during vaginal birth
  • Transmembrane transmission of the infection
  • Transplacental transmission of the infection

Additionally, silver nitrate drops (ocular prophylaxis) can cause ocular irritation and result in chemical conjunctivitis in newborn.[2]

Gross Pathology

On gross pathology, the following are characteristic findings of conjunctivitis:[5]

Microscopic histopathological analysis

On microscopic histopathological analysis, the following are characteristic findings of infective conjunctivitis in neonate:[6]

Images

The following are gross and microscopic images associated with conjunctivitis:

Causes

Neonatal conjunctivitis[2][8]

Differentiating ophthalmia neonatorum from Other Diseases

Neonatal conjunctivitis must be differentiated from:[2][8]

  • Dacrocysitis
  • Congenital glaucoma
  • Nasolacrimal duct obstruction
  • Preseptal/Orbital cellulitis
  • Keratitis

==Epidemiology and Demographics

Prevalence and Incidence

  • Worldwide, neonatal conjunctivitis or ophthalmia neonatorum still blinds approximately 10,000 babies annually.[9]

Gender=

  • The incidence of neonatal conjunctivitis does not vary by gender.[10]

Developed Countries

Prevalence of neonatal conjunctivitis has decreased significantly in developed countries since the abandonment of silver nitrate as topical prophylaxis. Current prevalence of neonatal conjunctivitis in developed countries are 5 per 1000 live births.[11]

  • In Belgium and Netherlands, the prevalence of neonatal conjunctivitis due to gonococcal infection was estimated 0.04 per 1000 live births.[2]
  • In the United States, the prevalence of neonatal conjunctivitis due to gonococcal infection was estiamted 0.3 per 1000 live births.
  • In the United States, the prevalence of neonatal conjunctivitis caused by chlamydial infection was estimated 5 to 60 cases per 1000 live births.
  • In the United Kingdom, the prevalence of neonatal conjunctivitis caused by chlamydial infection was estimated 4 cases per 1000 live births.[12]
  • In the United States, the incidence of bacterial conjunctivitis is 23,000 per 100,000 cases (in the 0-2 year age range), 28,000 per 100,000 cases (in the 3-9 year range), 13,000 per 100,000 cases (in the 10-19 year range) with the remaining 36,000 per 100,000 cases (in adults).[13]

Developing Countries

  • In the Africa, the incidence of neonatal conjunctivitis is still high.[12]

References

  1. "Red Book - Report of the Committee on Infectious Diseases, 29th Edition. The American Academy of Pediatrics". Retrieved 2007-07-12.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). "Neonatal conjunctivitis - a review". Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  3. "Reports from the obstetrical clinic in Leipzig. Prevention of eye inflammation in the newborn". Am J Dis Child. 121 (1): 3–4. 1971. PMID 5543850.
  4. Treadwell P (1994). "Sexually transmitted diseases in neonates and infants". Semin Dermatol. 13 (4): 256–61. PMID 7848819.
  5. National Eye Institute (2015) [1] Accessed on June 24, 2016
  6. DermNet NZ (2015)[2] Accessed on June 26, 2016
  7. http://picasaweb.google.com/mcmumbi/USMLEIIImages
  8. 8.0 8.1 Woods, Charles R. "Gonococcal infections in neonates and young children." Seminars in pediatric infectious diseases. Vol. 16. No. 4. WB Saunders, 2005.
  9. Isenberg SJ, Apt L, Wood M (1996). "The influence of perinatal infective factors on ophthalmia neonatorum". J Pediatr Ophthalmol Strabismus. 33 (3): 185–8. PMID 8771523.
  10. Moore DL, MacDonald NE, Canadian Paediatric Society, Infectious Diseases and Immunization Committee (2015). "Preventing ophthalmia neonatorum". Can J Infect Dis Med Microbiol. 26 (3): 122–5. PMC 4507834. PMID 26236350.
  11. Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  12. 12.0 12.1 Schaller UC, Klauss V (2001). "Is Credé's prophylaxis for ophthalmia neonatorum still valid?". Bull World Health Organ. 79 (3): 262–3. PMC 2566367. PMID 11285676.
  13. Epling J (2010). "Bacterial conjunctivitis". BMJ Clin Evid. 2010. PMC 2907624. PMID 21718563.


Template:WS Template:WH